Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · First Horizon (FHN)

First Horizon adds director Jeffrey Balser and expands board to 13 members

Neutral Impact 2 of 5 leadership

First Horizon Corporation's boards elected Jeffrey R. Balser, a physician and academic health system executive, to the board effective October 26, 2026, and amended the bylaws to increase the board from twelve to thirteen members. The filing reports no financial results, and the changes are governance matters that add one board seat and one new director.

Key points

  • Jeffrey R. Balser elected to the board effective immediately on October 26, 2026.
  • Balser is President and CEO of Vanderbilt University Medical Center and Dean of Vanderbilt University School of Medicine.
  • Balser appointed to the Nominating and Corporate Governance Committee and the Information Technology Committee.
  • Bylaw Section 3.2 amended October 26, 2026 to set the board at thirteen members, up from twelve.

The filing

CompanyFirst Horizon (FHN)
Form8-K, current report
Filed with the SECOct 27, 2026, 6:17 AM ET
Accession number0000036966-26-000184

Items reported: 5.02 Director / Officer Change5.03 Bylaw / Charter Amendment

Read the filing on SEC.gov ↗

Written by AI on Nov 7, 2026, 11:17 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.